SC
Swati Chaurasia Saxena
About Swati Chaurasia Saxena
Data last updated:
Swati Chaurasia Saxena is a Director at Endorfins Capital Private Limited (since 2021), Director at Sagi & Swati Trading Private Limited (since 2018) and Designated Partner at Endorfins Salvus Llp (since 2025), and holds 2 more current directorships. The companies operate in Financial Services, Business Services and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹22.5 Lakh; the largest is Endorfins Capital Private Limited at ₹12.5 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Endorfins Capital Private Limited U65999MP2021PTC055776 | Director | 13 Apr 2021 | 2021 | ₹12.5 Lakh (FY 2023) | Active |
| Sagi & Swati Trading Private Limited U74999MP2018PTC045457 | Director | 04 Apr 2018 | 2018 | ₹10 Lakh (FY 2020) | Active |
| Endorfins Salvus Llp ACR-2443 | Designated Partner | 10 Sep 2025 | 2025 | Active | |
| Endorfins Capital Solutions Private Limited U66120MP2025PTC077692 | Director | 07 Jul 2025 | 2025 | Active | |
| Chameleon Traders Club Llp ACC-1521 | Designated Partner | 22 Jul 2023 | 2023 | Active |
Board colleagues of Swati Chaurasia Saxena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashutosh Kumar Saxena | 08102532 | Endorfins Capital Private Limited , Sagi & Swati Trading Private Limited and 3 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swati Chaurasia Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swati Chaurasia Saxena
Swati Chaurasia Saxena currently holds 5 directorships: Endorfins Capital Private Limited (Director, since 13 Apr 2021, revenue ₹12.5 Lakh (FY 2023)); Sagi & Swati Trading Private Limited (Director, since 04 Apr 2018, revenue ₹10 Lakh (FY 2020)); Endorfins Salvus Llp (Designated Partner, since 10 Sep 2025); Endorfins Capital Solutions Private Limited (Director, since 07 Jul 2025); Chameleon Traders Club Llp (Designated Partner, since 22 Jul 2023).
Swati Chaurasia Saxena was first appointed on 04 Apr 2018 as Director at Sagi & Swati Trading Private Limited. The most recent appointment on record is 10 Sep 2025 at Endorfins Salvus Llp.
The 2 current companies of Swati Chaurasia Saxena that report revenue have a combined latest revenue of ₹22.5 Lakh: Endorfins Capital Private Limited ₹12.5 Lakh (FY 2023); Sagi & Swati Trading Private Limited ₹10 Lakh (FY 2020).
The current boards of Swati Chaurasia Saxena's companies include Ashutosh Kumar Saxena (Endorfins Capital Private Limited).